Shaping the Future of Respiratory Care: The ERS Alpha-1 Antitrypsin Conference 2026 on July 21, 2026 Posted by
The Spicy Paradox: Unpacking the Complex Relationship Between Chili Peppers and Cancer Risk on July 21, 2026 Posted by
Advancing the Frontier of Bipolar Disorder Treatment: From Magnetic Seizures to Metabolic Interventions on July 21, 2026 Posted by
Beyond Willpower: Why Your Body Changes After 50 and How to Reclaim Your Shape on July 21, 2026 Posted by
Medtronic Unveils Real-Time AI Platform: A New Era for Robotic-Assisted Surgery on July 21, 2026 Posted by
The "Black Box" Controversy: Data, Deception, and the Two-Decade Debate Over Youth Antidepressants on July 21, 2026 Posted by
Retinal Nerve Fiber Thickening Linked to Geographic Atrophy Treatments: A Clinical Conundrum on July 21, 2026 Posted by
Shaping the Future of Respiratory Care: The ERS Alpha-1 Antitrypsin Conference 2026 on July 21, 2026 Posted by
The Spicy Paradox: Unpacking the Complex Relationship Between Chili Peppers and Cancer Risk on July 21, 2026 Posted by
Advancing the Frontier of Bipolar Disorder Treatment: From Magnetic Seizures to Metabolic Interventions on July 21, 2026 Posted by
Beyond Willpower: Why Your Body Changes After 50 and How to Reclaim Your Shape on July 21, 2026 Posted by
Posted in Sleep Health FDA Grants Orphan Drug Designation to Tris Pharma’s TRN-257, a Potential Breakthrough for Idiopathic Hypersomnia on July 16, 2026
Posted in Respiratory Health Genetic Breakthrough: New Polygenic Risk Score Transforms Idiopathic Pulmonary Fibrosis Prognosis on July 14, 2026
Posted in Sleep Health The Hidden Burden: Cognitive Impairment in Narcolepsy and Idiopathic Hypersomnia on July 14, 2026
Posted in Sleep Health The Hidden Burden: New Study Reveals Cognitive Impairment as a Primary Driver of Disability in Narcolepsy and Idiopathic Hypersomnia on July 5, 2026
Posted in Sleep Health Beyond the Wakefulness Gap: How Cognitive Impairment Redefines Life with Narcolepsy and Idiopathic Hypersomnia on June 23, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
Posted in Sleep Health Breakthrough in Sleep Medicine: Alkermes’ LUMRYZ Shows Promise for Idiopathic Hypersomnia in Phase 3 Trial on June 2, 2026 rifanmuazin
Posted in Sleep Health Breakthrough in Sleep Medicine: Alkermes’ LUMRYZ Shows Promise for Idiopathic Hypersomnia in Phase 3 Study on May 22, 2026 rifanmuazin
Posted in Medical Innovations Regenerative Breakthrough: Oorja Bio Launches with $30M to Tackle Idiopathic Pulmonary Fibrosis on May 21, 2026 rifanmuazin
Posted in Respiratory Health Breakthrough in Idiopathic Pulmonary Fibrosis: TETON Trials Signal New Era for Nebulized Treprostinil on May 19, 2026 rifanmuazin
